New data on Lucentis

Novartis, a Swiss multinational pharmaceutical company, recently released new data to support the effectiveness and safety of its flagship ophthalmological drug, Lucentis.

 

At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, recently held in Vienna, Austria, Novartis presented the results from the REPAIR study, conducted over a year on British patients. They show that with an average of 9.7 injections of Lucentis over a five-year period, blindness attributable to AMD could be reduced by 59%.

 

The study also found that visual acuity improved in patients with myopic choroidal neovascularization, with an average of 3.6 injections.

 

Moreover, data from 22 studies support the evidence that the drug is safe, which still needs to be confirmed by a five-year, global study involving 30,000 patients.

 

In 2012, Novartis achieved net sales of $2.4 billion with Lucentis, and Roche, which distributes it in the United States, recorded earnings of $1.56 billion.

Source: http://www.bilan.ch/awp/novartis-presente-de-nouvelles-donnees-sur-lefficacite-du-lucentis-7

Featured Posts

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Learn More

In Perfect Harmony

Dress your eyes in a showstopping synchronous design from VANNI's Tandem collection.

Learn More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Read more

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses.

Read more

Companies Nominated at the 30th SILMO d’Or

The 2023 SILMO d'Or nominees are...

Read more

Nicolas Fafiotte Appointed President of the 2023 SILMO D’OR Awards

A graduate of the ESMOD School of Fashion Design, Nicolas Fafiotte trained in Paris before moving to Lyon in the early 2000s.

Read more

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Learn More

In Perfect Harmony

Dress your eyes in a showstopping synchronous design from VANNI's Tandem collection.

Learn More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Read More

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses.

Read More

Companies Nominated at the 30th SILMO d’Or

The 2023 SILMO d'Or nominees are...

Read More

Nicolas Fafiotte Appointed President of the 2023 SILMO D’OR Awards

A graduate of the ESMOD School of Fashion Design, Nicolas Fafiotte trained in Paris before moving to Lyon in the early 2000s.

Read More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Learn More

In Perfect Harmony

Dress your eyes in a showstopping synchronous design from VANNI's Tandem collection.

Learn More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Read more

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses.

Read more

Companies Nominated at the 30th SILMO d’Or

The 2023 SILMO d'Or nominees are...

Read more

Nicolas Fafiotte Appointed President of the 2023 SILMO D’OR Awards

A graduate of the ESMOD School of Fashion Design, Nicolas Fafiotte trained in Paris before moving to Lyon in the early 2000s.

Read more

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Learn More

In Perfect Harmony

Dress your eyes in a showstopping synchronous design from VANNI's Tandem collection.

Learn More

Transitions®: the clear lens that adapts to light for the perfect protection!

Did you know Transitions® has a lens for all your patients experiencing any level of light sensitivity?

Read more

SightGlass Vision Releases First White Paper on Diffusion Optics Technology™

SightGlass Vision announced the release of its first white paper regarding the company’s Diffusion Optics Technology™ (DOT 0.2) spectacle lenses.

Read more

Companies Nominated at the 30th SILMO d’Or

The 2023 SILMO d'Or nominees are...

Read more

Nicolas Fafiotte Appointed President of the 2023 SILMO D’OR Awards

A graduate of the ESMOD School of Fashion Design, Nicolas Fafiotte trained in Paris before moving to Lyon in the early 2000s.

Read more